- The trend backdrop is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
BMYS
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Latest close
55.76 EUR
-0.6%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 10.9% above the Trend Line and sits at 79.9% of its 52-week range. The latest completed week returned -0.6%, after a 11.1% four-week move. The latest news-sentiment score is 45/100.
Setup score
57
out of 100
Latest Close
55.76 EUR
7 Aug 2026
1W Return
-0.6%
latest completed week
4W Return
11.1%
short-term follow-through
12W Return
16.5%
quarterly tape
Trend Breadth
65.4%
34 of 52 weeks active
Volume Ratio
-
vs 13-week average
- 1 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
-0.6%
Latest completed week; four-week move 11.1%.
Indicator stack
57/81
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
45/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 10.9% above the Trend Line and sits at 79.9% of its 52-week range. The latest completed week returned -0.6%, after a 11.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6812-week average 0.66
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.1% over four weeks, 16.5% over 12 weeks, and 49.0% over one year. The current trend has remained active for 6 consecutive weeks.
Performance by holding period
Active trend streak6 weeks
Active weeks in one year34
Trend breadth65.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.75Latest activity-pressure read.
Pressure change215.8%Four-week change in activity pressure.
Leadership-0.26Latest relative-leadership reading.
RS change96.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment45/100
Weighted news tone is neutral across 9 relevant articles.
2 positive · 5 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.4%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+8.0%Week of 17 Jul.
Worst week-6.7%Week of 8 May.
Latest week-0.6%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains12
Flat weeks0
Modest losses9
Sharp losses2
Recent vol3.7%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank15 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Drug Manufacturers - General
4-week rank2 / 17
Group average3.5%
Trend breadth70.6%
Trend70.6%active weekly trend signals
MD88.2%positive activity pressure
RS11.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis50/100Latest 12-week confirmation: trend 10/12, activity pressure 3/12, relative leadership 3/12.
Activity pressure 0.68; 1 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment45/100Weighted news tone is neutral across 9 relevant articles.
Tuesday papers: AstraZeneca shares fall on Bristol Myers Squibb merger talks Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 55.76 EUR | -0.6% | 50.26 EUR | 44.04 EUR | 0.75 | -0.26 | 0 | On |
| 31 Jul 2026 | 56.11 EUR | 2.9% | 49.98 EUR | 43.99 EUR | 0.47 | 3.50 | 0 | On |
| 24 Jul 2026 | 54.55 EUR | 0.7% | 49.62 EUR | 43.94 EUR | 0.14 | 0.78 | 0 | On |
| 17 Jul 2026 | 54.19 EUR | 8.0% | 49.29 EUR | 43.90 EUR | -0.16 | 1.54 | 0 | On |
| 10 Jul 2026 | 50.17 EUR | -0.3% | 48.99 EUR | 43.87 EUR | -0.65 | -7.79 | 124 | On |
| 3 Jul 2026 | 50.30 EUR | 1.1% | 48.77 EUR | 43.86 EUR | -0.86 | -8.87 | 0 | On |
| 26 Jun 2026 | 49.76 EUR | 6.4% | 48.56 EUR | 43.85 EUR | -1.01 | -7.81 | 0 | Off |
| 19 Jun 2026 | 46.75 EUR | -4.0% | 48.27 EUR | 43.86 EUR | -1.16 | -15.16 | 0 | Off |
| 12 Jun 2026 | 48.68 EUR | -1.2% | 48.01 EUR | 43.89 EUR | -0.93 | -8.22 | 0 | On |
| 5 Jun 2026 | 49.28 EUR | 2.9% | 47.69 EUR | 43.90 EUR | -0.93 | -4.78 | 0 | On |
| 29 May 2026 | 47.90 EUR | -5.3% | 47.37 EUR | 43.92 EUR | -0.93 | -8.62 | 10 | On |
| 22 May 2026 | 50.58 EUR | 5.7% | 47.07 EUR | 43.95 EUR | -0.64 | -1.09 | 192 | On |
| 15 May 2026 | 47.86 EUR | 1.4% | 46.60 EUR | 43.96 EUR | -0.66 | -4.56 | 0 | On |
| 8 May 2026 | 47.19 EUR | -6.7% | 46.22 EUR | 43.98 EUR | -0.44 | -6.41 | 0 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.